Deploying more than 100 GPUs trains neural networks on terabytes of data each week. The company runs 250 terabytes of data through its machine learning algorithms each month to identify drug candidates for human diseases.
Recursion Pharmaceuticals uses deep learning to discover drug candidates for hundreds of rare diseases.